SCOPUS 정보 검색 플랫폼

Nephrology Dialysis Transplantation

Volumn 11, Issue 6, 1996, Pages 1079-1083

Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients

(4) Taylor, J E a,b Peat, N a Porter, C a Morgan, A G a

a NOTTINGHAM CITY HOSPITAL (United Kingdom)

b DORSET COUNTY HOSPITAL (United Kingdom)

Author keywords

Erythropoietin; Haemodialysis; Intravenous iron

Indexed keywords

ERYTHROPOIETIN; FERRIC GLUCONATE; FERRITIN; HEMOGLOBIN; IRON;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY; IRON THERAPY; MALE; PRIORITY JOURNAL;

EID: 0029898504 PISSN: 09310509 EISSN: None Source Type: Journal
DOI: 10.1093/oxfordjournals.ndt.a027459 Document Type: Article

Times cited : (120)

References (8)

1
- 0029055794
- RHuEpo hyporesponsiveness-who and why?
- Danielson B. RHuEpo hyporesponsiveness-who and why? Nephrol Dial Transplant 1995; 10 [suppl 2]: 69-73
- (1995) Nephrol Dial Transplant , vol.10 , Issue.2 SUPPL. , pp. 69-73
- Danielson, B.¹

2
- 0002629026
- Iron supplementation of hemodialysis patients receiving recombinant human erythropoietin therapy
- Bauer C, Koch KM, Scigalla P, Wieczorak L eds. Marcel Dekker, New York
- Granolleras C, Oules R, Branger B, Fourcade J, Shaldon S. Iron supplementation of hemodialysis patients receiving recombinant human erythropoietin therapy. In: Bauer C, Koch KM, Scigalla P, Wieczorak L eds. Erythropoietin: Molecular Physiology and Clinical Applications. Marcel Dekker, New York, 1993; 211-218
- (1993) Erythropoietin: Molecular Physiology and Clinical Applications , pp. 211-218
- Granolleras, C.¹ Oules, R.² Branger, B.³ Fourcade, J.⁴ Shaldon, S.⁵

3
- 0020144203
- Diagnostic methods
- Cavill I. Diagnostic methods. Clin Haematol 1982; 11: 259-273
- (1982) Clin Haematol , vol.11 , pp. 259-273
- Cavill, I.¹

4
- 0026512123
- Detection of functional iron deficiency during erythropoietin treatment: A new approach
- Macdougall IC, Cavill I, Hulme B et al. Detection of functional iron deficiency during erythropoietin treatment: a new approach. Br Med J 1992; 304: 225-226
- (1992) Br Med J , vol.304 , pp. 225-226
- Macdougall, I.C.¹ Cavill, I.² Hulme, B.³

5
- 0027970022
- Intravenous iron-sucrose complex to reduce epoietin demand in dialysis patients
- Nyvad O, Danielsen H, Madsen S. Intravenous iron-sucrose complex to reduce epoietin demand in dialysis patients. Lancet 1994; 344: 1305-1306
- (1994) Lancet , vol.344 , pp. 1305-1306
- Nyvad, O.¹ Danielsen, H.² Madsen, S.³

6
- 0010046305
- Optimising low dose r-HuEPO combined with low dose I.V. Iron therapy in haemodialysis patients
- Sunder-Plassmann G, Horl WH. Optimising low dose r-HuEPO combined with low dose I.V. iron therapy in haemodialysis patients J Am Soc Nephrol 1994; 5: 478
- (1994) J Am Soc Nephrol , vol.5 , pp. 478
- Sunder-Plassmann, G.¹ Horl, W.H.²

7
- 0001402276
- A randomised control study of iron supplementation in patients treated with erythropoietin
- Macdougall IC, Tucker B, Thompson J, Baker LRI, Raine AEG. A randomised control study of iron supplementation in patients treated with erythropoietin. J Am Soc Nephrol 1993; 4:428
- (1993) J Am Soc Nephrol , vol.4 , pp. 428
- Macdougall, I.C.¹ Tucker, B.² Thompson, J.³ Baker, L.R.I.⁴ Raine, A.E.G.⁵

8
- 0026679838
- Structure/histotoxicity relationship of parenteral iron preparations
- Geisser P, Baer M, Schaub E. Structure/histotoxicity relationship of parenteral iron preparations. Arzneimittel-Forschung 1992; 42: 1439-1452
- (1992) Arzneimittel-Forschung , vol.42 , pp. 1439-1452
- Geisser, P.¹ Baer, M.² Schaub, E.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.